Department of Biosciences, Biotechnology and Environment, University of Bari 'A. Moro', Bari, Italy.
Laboratory of Molecular Pathology and Experimental Oncology, Institute of Translational Pharmacology, Consiglio Nazionale delle Ricerche, Rome, Italy.
Methods Mol Biol. 2024;2773:51-58. doi: 10.1007/978-1-0716-3714-2_5.
Recent progress in developing new vaccination strategies against cancer requires the production of complex and reliable animal models reflecting the complexity of the tumors with their microenvironment. Mice can be considered a good source due to low cost and ease of being genetically modified, inoculated with tumor cell lines or treated by chemicals to induce different cancers. Despite significant limitations in modeling human cancer complexity, preclinical trials conducted in mice can efficiently contribute to understand molecular mechanisms of cancer, to closely resemble and follow carcinogenesis steps impossible to study into humans, and to test new anticancer therapies. In this chapter, we generally describe the different mouse models developed for cancer vaccines' preclinical trials. A particular focus is dedicated to a chemically-induced colorectal cancer model in use in our laboratories.
最近在开发针对癌症的新型疫苗接种策略方面取得的进展需要生产复杂且可靠的动物模型,以反映肿瘤及其微环境的复杂性。由于成本低且易于进行基因改造,因此可以将小鼠视为良好的来源,可以用肿瘤细胞系接种或用化学物质处理以诱导不同的癌症。尽管在模拟人类癌症的复杂性方面存在重大局限性,但在小鼠中进行的临床前试验可以有效地帮助我们了解癌症的分子机制,更密切地模拟和跟踪在人类中无法研究的致癌步骤,并测试新的抗癌疗法。在本章中,我们一般描述了为癌症疫苗的临床前试验开发的不同小鼠模型。特别关注我们实验室中使用的化学诱导结直肠癌模型。